Literature DB >> 30028408

NOVEL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKER IN BRANCH RETINAL VEIN OCCLUSION MACULAR EDEMA.

Ling Yeung1,2, Wei-Chi Wu3,2, Lan-Hsin Chuang1,2, Nan-Kai Wang3,2, Chi-Chun Lai3,2.   

Abstract

PURPOSE: To evaluate the association between deep-superficial flow ratio (DSFR) and the treatment response of macular edema in branch retinal vein occlusion.
METHODS: Thirty eyes from 30 patients with branch retinal vein occlusion who had received optical coherence tomography angiography examination were included. Seventeen normal fellow eyes acted as the control group. Patients were classified into the "good response group" and the "refractory group" by absence or presence of macular edema after 6 months of treatment. The DSFRs were calculated by dividing deep capillary plexus vessel density by superficial capillary plexus vessel density on optical coherence tomography angiography.
RESULTS: The DSFR was 1.00 (SD ± 0.05) over parafoveal area in the control group. Among branch retinal vein occlusion eyes, parafoveal DSFR remained stable in the good response group (P = 0.822) and significantly decreased in the refractory group (P = 0.002). The DSFRs in the most severe nonperfusion area were significantly lower in the refractory group than in the good response group (0.85 ± 0.13 vs. 1.01 ± 0.15, P = 0.004). The DSFR in the most severe nonperfusion area was associates with treatment response in multivariate logistic regression (P = 0.015).
CONCLUSION: Deep-superficial flow ratio can represent the relative damage of deep capillary plexus to superficial capillary plexus. Decreased DSFR was found in branch retinal vein occlusion eyes with refractory macular edema.

Entities:  

Year:  2019        PMID: 30028408     DOI: 10.1097/IAE.0000000000002264

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

Review 1.  [Biomarkers in the treatment of retinal vein occlusion].

Authors:  Jakob Siedlecki; Lars-Olof Hattenbach; Nikolas Feltgen; Siegfried G Priglinger
Journal:  Ophthalmologie       Date:  2022-10-06

2.  Characteristics of macular microvasculature before and after idiopathic macular hole surgery.

Authors:  Dan Cheng; Ji-Wei Tao; Xue-Ting Yu; Yi-Qi Chen; Mei-Xiao Shen; Min-Hui Wu; Jia-Feng Yu; Heng-Li Lian; Zhe Lu; Li-Jun Shen
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

3.  Updating Understanding of Macular Microvascular Abnormalities and Their Correlations With the Characteristics and Progression of Macular Edema or Exudation in Coats' Disease.

Authors:  Juan Zhang; Lu Ruan; Chen Jiang; Qian Yang; Yuqiao Ju; Qing Chang; Xin Huang
Journal:  Front Med (Lausanne)       Date:  2022-04-13

4.  Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema.

Authors:  Young Gun Park; Young-Hoon Park
Journal:  J Diabetes Res       Date:  2020-11-16       Impact factor: 4.011

5.  Wide-field swept-source OCT angiography of the periarterial capillary-free zone before and after anti-VEGF therapy for branch retinal vein occlusion.

Authors:  Wenyi Tang; Wei Liu; Jingli Guo; Lili Zhang; Gezhi Xu; Keyan Wang; Qing Chang
Journal:  Eye Vis (Lond)       Date:  2022-07-02

6.  Macular Ischemia Quantification Using Deep-Learning Denoised Optical Coherence Tomography Angiography in Branch Retinal Vein Occlusion.

Authors:  Ling Yeung; Yih-Cherng Lee; Yu-Tze Lin; Tay-Wey Lee; Chi-Chun Lai
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

7.  Correlation between macular edema recurrence and macular capillary network destruction in branch retinal vein occlusion.

Authors:  Ji Hye Jang; Yu Cheol Kim; Jae Pil Shin
Journal:  BMC Ophthalmol       Date:  2020-08-24       Impact factor: 2.209

8.  Treatment responses for branch retinal vein occlusion predicted by semi-automated fluorescein angiography quantification.

Authors:  Pei-Wei Huang; Chi-Chun Lai; Yih-Shiou Hwang; Wei-Chi Wu; Cheng-Hsiu Wu; Jerry Chien-Chieh Huang; Yen-Po Chen; Laura Liu; Kuan-Jen Chen; Ling Yeung
Journal:  BMC Ophthalmol       Date:  2022-02-02       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.